55pharma is a small-cap pharmaceutical company that develops ethical, patent-protected pharmaceutical drugs. After pre-clinical and early-stage clinical trials, we sell our drug candidates to big pharmaceutical companies. Our systematic, high-value discovery approach results in higher success rates in the cost-intensive clinical development and, ultimately, in truly innovative drugs: As a starting point, we use medicinal plants with a known medical benefit in humans. From these, we isolate the bioactive principle and protect the molecules responsible for the therapeutic effect with international patent rights. 55pharma’s enabling technology platform provides the ability to discover potential first-in-class small molecule drugs descended from nature and to maintain a product pipeline which is developed in-house and used as a basis for future Big Pharma partnerships. We focus on type 2 diabetes, one of today’s blockbuster indications.